An FDA analysis of trial data for Eli Lilly’s experimental Alzheimer’s drug donanemab released on Thursday revealed no red flags, but raised questions about safety of the treatment for patients with early-stage disease. The drug is a potential rival to Eisai and Biogen’s… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]
Published on June 6, 2024
The White House is calling on hospital executives, doctors, and other health care leaders to take bolder steps to prevent gun violence by gathering more data about gunshot injuries and routinely counseling patients about safe use of firearms. Biden administration officials are hosting back-to-back events Thursday and Friday at the White House for about 160 […]
Published on June 6, 2024
Large Language Models behind popular generative AI platforms like ChatGPT gave different answers when asked to respond to the same reasoning test and didn’t improve when given additional context, finds a new study. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of […]
Published on June 5, 2024